We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese (CE) Up 19% in a Year: What's Going in its Favor?
Read MoreHide Full Article
Shares of Celanese Corporation (CE - Free Report) have moved up around 19.1% in the past year compared with the industry’s rise of roughly 5.6%.
Celanese, a Zacks Rank #1 (Strong Buy) stock, has a market cap of roughly $15.7 billion. Average volume of shares traded in the past three months was around 917.6K. The company has expected long-term earnings per share growth of 10%.
Let’s take a look at the factors that are driving this chemical company.
Driving Factors
An impressive second quarter, upbeat outlook, strength in Engineered Materials (EM) and Acetyl Chain units along with strategic measures including acquisitions and operational cost savings have contributed to the rally in Celanese’s shares.
In the second quarter, Celanese’s earnings jumped 47% year over year to $2.52 per share and adjusted earnings surged 62% to $2.90. The figure also surpassed the Zacks Consensus Estimate of $2.40. Revenues rose roughly 22% year over year to $1,844 million in the quarter, outpacing the Zacks Consensus Estimate of $1,789 million.
In its second-quarter earnings call, Celanese stated that it expects the momentum in Acetyl Chain to continue in the third quarter. The project pipeline also continues to advance in EM. Moreover, the company expects to deliver free cash flow of more than $1 billion in the year.
Sales and income from the EM units jumped year over year in the second quarter supported by growth in Asia and the Americas, better product mix, recent acquisitions and project commercialization. Celanese commercialized 733 projects in the EM segment during the second quarter, up 34% year over year, and is on track to deliver nearly 3,000 project wins in 2018.
Celanese is also focused on growth through acquisitions. The purchase of Italy-based SO.F.TER. Group strengthened Celanese’s solutions capability and project pipeline. Moreover, the acquisition of Nilit's nylon compounding unit is in sync with Celanese’s plans to become a leading nylon compound supplier. The buyout enables the company to extend global leadership position in the EM business as nylon continues to be adopted in automotive, consumer and industrial applications.
Moreover, the recent buyout of Omni Plastics reinforces Celanese’s global asset base by adding compounding capacity in the Americas, which will allow the company to continue supporting a diverse and growing customer base.
The company raised its adjusted EPS guidance for 2018 to roughly $10.50-$10.75 factoring in strength across the EM and Acetyl Chain units. The company’s strategic initiatives including cost savings through productivity actions and efficiency enhancement are expected to continue to drive earnings.
Other top-ranked stocks in the basic materials space include Ingevity Corporation (NGVT - Free Report) , Huntsman Corporation (HUN - Free Report) and Air Products and Chemicals, Inc. (APD - Free Report) .
Huntsman has an expected long-term earnings growth rate of 8.5% and a Zacks Rank #1. The stock has gained 14.5% in a year.
Air Products has an expected long-term earnings growth rate of 16.1% and a Zacks Rank #2 (Buy). Shares of the company have risen 14.4% in a year’s time.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Image: Bigstock
Celanese (CE) Up 19% in a Year: What's Going in its Favor?
Shares of Celanese Corporation (CE - Free Report) have moved up around 19.1% in the past year compared with the industry’s rise of roughly 5.6%.
Celanese, a Zacks Rank #1 (Strong Buy) stock, has a market cap of roughly $15.7 billion. Average volume of shares traded in the past three months was around 917.6K. The company has expected long-term earnings per share growth of 10%.
Let’s take a look at the factors that are driving this chemical company.
Driving Factors
An impressive second quarter, upbeat outlook, strength in Engineered Materials (EM) and Acetyl Chain units along with strategic measures including acquisitions and operational cost savings have contributed to the rally in Celanese’s shares.
In the second quarter, Celanese’s earnings jumped 47% year over year to $2.52 per share and adjusted earnings surged 62% to $2.90. The figure also surpassed the Zacks Consensus Estimate of $2.40. Revenues rose roughly 22% year over year to $1,844 million in the quarter, outpacing the Zacks Consensus Estimate of $1,789 million.
In its second-quarter earnings call, Celanese stated that it expects the momentum in Acetyl Chain to continue in the third quarter. The project pipeline also continues to advance in EM. Moreover, the company expects to deliver free cash flow of more than $1 billion in the year.
Sales and income from the EM units jumped year over year in the second quarter supported by growth in Asia and the Americas, better product mix, recent acquisitions and project commercialization. Celanese commercialized 733 projects in the EM segment during the second quarter, up 34% year over year, and is on track to deliver nearly 3,000 project wins in 2018.
Celanese is also focused on growth through acquisitions. The purchase of Italy-based SO.F.TER. Group strengthened Celanese’s solutions capability and project pipeline. Moreover, the acquisition of Nilit's nylon compounding unit is in sync with Celanese’s plans to become a leading nylon compound supplier. The buyout enables the company to extend global leadership position in the EM business as nylon continues to be adopted in automotive, consumer and industrial applications.
Moreover, the recent buyout of Omni Plastics reinforces Celanese’s global asset base by adding compounding capacity in the Americas, which will allow the company to continue supporting a diverse and growing customer base.
The company raised its adjusted EPS guidance for 2018 to roughly $10.50-$10.75 factoring in strength across the EM and Acetyl Chain units. The company’s strategic initiatives including cost savings through productivity actions and efficiency enhancement are expected to continue to drive earnings.
Celanese Corporation Price and Consensus
Celanese Corporation Price and Consensus | Celanese Corporation Quote
Other Stocks to Consider
Other top-ranked stocks in the basic materials space include Ingevity Corporation (NGVT - Free Report) , Huntsman Corporation (HUN - Free Report) and Air Products and Chemicals, Inc. (APD - Free Report) .
Ingevity has an expected long-term earnings growth rate of 12% and carries a Zacks Rank #1. Shares of the company have rallied 56.3% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Huntsman has an expected long-term earnings growth rate of 8.5% and a Zacks Rank #1. The stock has gained 14.5% in a year.
Air Products has an expected long-term earnings growth rate of 16.1% and a Zacks Rank #2 (Buy). Shares of the company have risen 14.4% in a year’s time.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>